Returning for its 2nd year as the world’s leading industry forum, Dry-AMD Therapeutic Development establishes meaningful clinical endpoints using the latest diagnostic imaging techniques to prove therapeutic safety and efficacy in specific patient populations. In the context of unprecedented Phase III progress, and as new investigational pharmacological agents enter the clinic, Dry-AMD Therapeutic Development will deliver […]

Exploring therapeutic applications of connected on-body devices The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and […]

As the most comprehensive, industry-focused and ‘must-attend’ event in the field, the 4th Targeted Protein Degradation Summit returns to once again explore the latest approaches, perspectives, and data-drive case studies that will continue to advance PROTACs, molecular glues, and other degrader modalities towards clinical success. With 70+ world-class speakers and over 500 senior attendees from […]

Discover the Intricacies of Complement Pathways to Accelerate Clinical Validation & Maximize Complement-Targeting in the Pan-Disease Setting Built with Alexion, Apellis and Annexon, the 5th Complement-based Drug Development Summit returns for its fifth year as the definitive industry dedicated forum to maximize complement-targeting in the pan-disease setting. With pivotal clinical readouts poised to be released […]

Your Comprehensive End-to-End Guide to Transforming the Clinical Development of Cell & Vaccine Based Neoantigen Therapies The growth and comeback of the neoantigen space has resulted in an abundance of new data, innovative insights and valuable lessons learned on how to drive meaningful clinical responses, all of which will be shared at the 6th Neoantigen […]

At the virtual 2nd Supply Chain and Logistics for Cell Therapies Summit, your community will gather to network, share exclusive insights in case-study led sessions, and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale. Implement robust, patient-centric supply chains for clinical to commercial readiness: Build your supply strategyand manage risk and forecasting at scale by designing for […]

Real-world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs, drug developers can now improve their clinical trial success by identifying and retaining suitable patients through increased patient stratification. These are exciting times to reunite at the 9th Advanced Real-World […]

The series brings together a global audience and global lineup of biocatalyst and protein modifications specialists to share how to implement the new technologies. With the applications growing across pharmaceutical, flavour & fragrance, consumer goods, food & beverage and agrochemical sectors, we have created a protein and enzyme engineering platform that will allow the community […]

The 5th Antifibrotic Drug Development Summit will provide a unique opportunity to gain cross-discipline actionable insights into how the latest scientific research is being applied to fibrosis pipeline progress. Network with industry pioneers in hot areas of drug development, specifically IPF, NASH, scleroderma, IBD, ILD, CKD, and more to apply disease-specific lessons agnostically, and understand […]

The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies, ADCs, and precision oncology to address the large unmet clinical need in GI cancers. **This meeting is free-to-attend for drug developers, research institutions, and not-for-profit organizations**. Register free to attend here: https://ter.li/t83wdr    This industry-dedicated […]

Understanding the most recent developments in enzyme-catalyzed processes, computational technologies, and cutting-edge methodologies in biocatalytic cascade reactions is key to help the API and chemical industries apply biocatalysis more effectively. Specifically designed alongside experts in the field, this conference will delve into the key technology, enzyme design, manufacturing, and scale-up challenges that must be overcome […]

LEAP TA: Life Sciences is a unique open platform for the boldest talent leaders in the industry to engage in genuinely disruptive dialogues. Meet 80+ of your peers to rethink your recruitment approach, allowing you to find better people faster in an increasingly competitive talent market. Taking part in this live online event will help you […]

As reports predict the global biomarker test market will exceed $16bn in coming years, the ability to identify and utilize predictive, diagnostic and prognostic biomarkers is a priority for drug developers. In rare disease, affecting over 400 million worldwide and where clinical insights exist for only around 400 of the 7000+ disease identified, biomarkers are […]

Navigating new legislations and strategies to comply with regulatory requirements SMi is proud to announce the launch of their Medical Devices and IVD conference to be held in London in November 2021. The MDR and IVDR updates will have a profound impact on the medical device industry, bringing certain products into regulatory scope that were […]

In the unprecedented array, and steady stream of novel, topical, and systemic agents entering various phases of drug development, for critical inflammatory and autoimmune dermatological conditions this year, the 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases, returns to Boston for 2021. As the world’s leading, and only forum committed to overcoming significant R&D hurdles, and sharing […]

Discover the Intricacies of Inflammasome Regulation, Leverage Inflammasome Proteins as Biomarkers & Accelerate Novel Inflammasome Therapeutics into Proof-Of-Concept Clinical Trials & Beyond Built with Ventus Therapeutics, Inflammasome Therapeutics, Merck & more, the Inflammasome Therapeutics Summit returns for its third year as the only industry-dedicated forum to discover the intricacies of inflammasome regulation and accelerate novel […]

The 3rd Exosome-Based Therapeutic Development Summit returns with a more comprehensive agenda than ever before, reuniting leading pharma, biotech, technology providers and academic teams to advance therapeutically relevant exosome-based therapeutics in regenerative medicine, autoimmunity, COVID-19 and beyond. Deep diving into the key challenges such as sourcing, characterization, cargo loading, manufacturing and clinical development, this year’s […]

The Wnt & β-Catenin Targeted Drug Discovery Summit is the only meeting uniting leading pharma, pioneering biotechs and reputed academics under a mutual and ambitious objective of accelerating your novel Wnt/β-catenin candidates into clinic and market. Built with Leap Therapeutics, Fog Pharma, Surrozen, Iterion Therapeutics, Genentech, and other leading companies, the summit will allow you to gain knowledge […]

Microbiome Connect: Gut Therapeutics USA, a two-day conference from the 17th – 18th of November 2021 and will bring you essential solutions to the challenges you face in the microbiome field. This industry-leading event will facilitate discussions concerning new clinical research, microbiome biomarkers, the latest regulatory developments, gut-organ axis, human clinical updates and much more. […]

The Oral Microbiome is the second largest and diverse microbiota in the human body, harboring over 700 species of bacteria. A complex and constantly changing habitat, it is crucial in maintaining not only oral health and oral diseases, but systemic health conditions across the body. To date, over 50 systemic diseases have been linked to an unbalanced […]

Love the skin you’re in? How about the bugs on it? Over the six years we’ve run Microbiome Connect: Skin, the field has changed drastically. In a short period, the field has gone from fringe to mainstream, from quantifying the size of bacterial populations to understanding their function. As the field continues to commercialize, it is time to ask […]

Virtual Expo Connect” is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. Powered by PharmaSources.com, Virtual Expo Connect builds an online platform to be accessed from anywhere, adding valued services and infinite opportunities to connect, learn, trade and grow. To know more visit: https://bit.ly/3ASODPZ

Exploring the future of ocular drug development SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on the 22nd-23rd of November 2021, in London. The global ophthalmic drug market is forecast to surpass $60 billion USD by 2025 with increasing focus from the industry on alternative delivery approaches and improving the effectiveness of […]

Grounding the scientific data into actionable insights for drug sponsors, the 5th NASH Summit is the outstanding forum and unrivalled platform for biotech and pharma to regroup, reassess and realign their NASH pipeline strategy. Uniting 100+ NASH experts from the EMA, Novartis, Gilead, Pfizer, Eli Lilly, Takeda, AstraZeneca, Merck, Janssen, Ionis, Novo Nordisk, the FDA and more, including […]

The only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications. This comprehensive, drug development focused agenda will showcase the latest concepts and molecular engineering approaches […]

Marrying unmissable insights from global renal experts, the 1st Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline. Hear from industry heavyweights including Sanofi Genzyme, Alexion, AstraZeneca, Regulus Therapeutics, Chinook […]

Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS. With 40+ expert leaders from the likes of Taysha Gene Therapies, Passage Bio, AskBio, Neurogene, Affinia Therapeutics and Alcyone […]

Capitalize on the Scalable & Diverse Potential of iPSC-Derived Therapies By Defining Differentiation Protocols, Optimal Cell Line Selection & Optimizing Gene Engineering To Accelerate Successfully Into the Clinic The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing its place as the […]

Engineer 'Intelligent', Controllable Drugs at the First Technical Meeting Dedicated to Advancing the Therapeutic Applications of Synthetic Biology This year, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially. The therapeutic potential of novel synthetic units is huge, […]

The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a crucial time for the entire industry. Spurred on by positive Phase III VISION trial data, there has been huge research investment, on both sides of the Atlantic, on how to deliver radiation therapy directly and specifically to tumours. For the 2021 edition of this conference, there will be the opportunity to […]